about
Physiology and pathophysiology of cyclooxygenase-2 and prostaglandin E2 in the kidneyAngiotensin II regulates V2 receptor and pAQP2 during ureteral obstructionCandesartan prevents long-term impairment of renal function in response to neonatal partial unilateral ureteral obstruction.High altitude may alter oxygen availability and renal metabolism in diabetics as measured by hyperpolarized [1-(13)C]pyruvate magnetic resonance imaging.Oxygen tension correlates with regional blood flow in obstructed rat kidney.15-Deoxy-Δ12,14-prostaglandin J2 Exerts Antioxidant Effects While Exacerbating Inflammation in Mice Subjected to Ureteral Obstruction.Megalin dependent urinary cystatin C excretion in ischemic kidney injury in rats.Urinary tract obstruction induces transient accumulation of COX-2-derived prostanoids in kidney tissueRegulation of aquaporins and sodium transporter proteins in the solitary kidney in response to partial ureteral obstruction in neonatal rats.Increased cyclooxygenase-2 expression and prostaglandin E2 production in pressurized renal medullary interstitial cells.Treatment with the vascular disrupting agent combretastatin is associated with impaired AQP2 trafficking and increased urine output.Chitosan/siRNA nanoparticles targeting cyclooxygenase type 2 attenuate unilateral ureteral obstruction-induced kidney injury in mice.Bilateral ureteral obstruction induces early downregulation and redistribution of AQP2 and phosphorylated AQP2.Insufficient insulin administration to diabetic rats increases substrate utilization and maintains lactate production in the kidneyα-Melanocyte stimulating hormone treatment in pigs does not improve early graft function in kidney transplants from brain dead donorsGlycogen synthase kinase 3α regulates urine concentrating mechanism in mice.No Effect of Remote Ischemic Conditioning Strategies on Recovery from Renal Ischemia-Reperfusion Injury and Protective Molecular MediatorsTesting Danegaptide Effects on Kidney Function after Ischemia/Reperfusion Injury in a New Porcine Two Week Model.Disruption of cyclooxygenase type 2 exacerbates apoptosis and renal damage during obstructive nephropathyDevelopment of intestinal ischemia/reperfusion-induced acute kidney injury in rats with or without chronic kidney disease: Cytokine/chemokine response and effect of α-melanocyte-stimulating hormone.Remote ischemic perconditioning attenuates ischemia/reperfusion-induced downregulation of AQP2 in rat kidney.Renoprotective Effects of Metformin are Independent of Organic Cation Transporters 1 &2 and AMP-activated Protein Kinase in the KidneyUreteral Access Sheath Influence on the Ureteral Wall Evaluated by Cyclooxygenase-2 and Tumor Necrosis Factor-α in a Porcine ModelUrinary biomarkers in prenatally diagnosed unilateral hydronephrosis.Ontogeny of the mammalian kidney: expression of aquaporins 1, 2, 3, and 4.Postoperative C-reactive protein concentration and clinical outcome: comparison of open cystectomy to robot-assisted laparoscopic cystectomy with extracorporeal or intracorporeal urinary diversion in a prospective study.Estradiol regulates AQP2 expression in the collecting duct: a novel inhibitory role for estrogen receptor α.Urinary proteome analysis in congenital bilateral hydronephrosis.Association between endothelial dysfunction and depression-like symptoms in chronic mild stress model of depression.Urine liver fatty acid binding protein and chronic kidney disease progression.Detection and quantification of intracellular bacterial colonies by automated, high-throughput microscopy.Mineralocorticoid versus glucocorticoid receptor occupancy mediating aldosterone-stimulated sodium transport in a novel renal cell line.Pressure and stretch differentially affect proliferation of renal proximal tubular cells.Stimulation of 11-beta-hydroxysteroid dehydrogenase type 2 in rat colon but not in kidney by low dietary NaCl intake.Cyclooxygenase 2 inhibition exacerbates AQP2 and pAQP2 downregulation independently of V2 receptor abundance in the postobstructed kidney.Rapid inhibition of vasoconstriction in renal afferent arterioles by aldosterone.Cardioprotective effect of L-glutamate in obese type 2 diabetic Zucker fatty rats.COX-2 inhibition prevents downregulation of key renal water and sodium transport proteins in response to bilateral ureteral obstruction.ROS dependence of cyclooxygenase-2 induction in rats subjected to unilateral ureteral obstruction.Evaluation of robot-assisted laparoscopic versus open cystectomy and effect of carbon dioxide-pneumoperitoneum on histopathological findings in ureteroenteric anastomoses: results from an experimental randomized porcine study.
P50
Q26771378-5766ED2A-BC25-4358-875A-C2644DFC66B5Q28580496-A92E1692-11D8-4BBB-AE68-3D99DCC274F9Q31065777-7BCAAD7C-B5D0-4B20-B514-476EFF01B972Q33460332-7679FE05-D8E2-440C-8F64-F7DF35031962Q33502566-02E92104-7724-495A-9CEC-B074C40C4287Q33631228-0BEFC87E-361E-4D16-812C-A6BA2516E111Q33757885-A4BBC6E5-8A02-43F3-B238-363A808C013EQ33784332-98403030-006B-415F-813D-03E0264D9A40Q33933990-B270FD6F-B8FB-4253-8789-B620BC66DFACQ34150167-6F8A2088-696E-4821-8A9F-4171891F2EFFQ34279269-56939BED-DD84-4368-B016-11A6E21BA29BQ34785218-8DE2FB2A-BCEE-4FD3-96CA-EA0174BFD1C6Q35086975-0AF8B8F5-620D-416D-AD3A-CA8555DE470CQ35094177-B0FD81B2-7290-452A-9982-F0462995DC35Q35146704-A71F8001-B805-450B-B77D-83070F4F859BQ35178606-7B19B12D-108C-4F20-84DB-20D103E869F1Q35882589-55CAF3ED-EDFD-41BD-BEE8-FE51EE000ABBQ36168047-0E2C337C-C0B6-4CCA-9D8F-CEFB68DDE75CQ36382109-64EC804C-1D67-4274-A6DA-6BD344828FE9Q36466000-1A77F2C4-9AB7-48F6-BC3E-29109A707990Q37096398-91771244-AEF2-4AE5-B432-4089594D274BQ37366972-08896EBE-2EF5-48F7-9C6B-B2F615103ADFQ37698335-959B6DCD-6076-4081-AD41-16128D9915F1Q37827242-FD4E69C1-7699-4319-A653-88437634849AQ38291076-30646B0A-F15E-4547-B732-1971EAE278F5Q38692951-DE6FC5B2-24FD-44BD-A8C2-BD61C389A353Q38865253-579980DE-C977-4C45-B80D-90D6128A02A6Q39243554-988EF2FF-BD9D-4D83-B119-5FF602B32E75Q39264786-AA1CD65A-5626-460C-A6C4-B50D16794433Q40107790-9A5B0787-3F1C-4F4E-8F97-11EB45FC6D15Q40224001-CF32958D-E6C2-45B4-836A-978B57E518D1Q40451493-B8449704-E747-405A-A172-3DA04E9BC9C4Q41037977-4EA5D1D0-F034-4CE4-86AD-EF14015FA20AQ42169138-5DCAB3BF-F73E-4A35-B44A-06877DC5E288Q43182529-DFE95FE7-E9C7-4987-979E-C90470B60AEFQ44654274-19D067CE-1257-4164-AC81-F1B823C8E8CDQ46082728-423C16DA-8DAA-4E0F-8B61-0E098DC3877BQ46446037-5615F7EB-D91D-4921-9C36-D9A5E16D268CQ46971883-DD625515-79CD-4EDC-B759-A6B97945A094Q47956395-6B70E05A-B796-4E22-A3D2-90D326D6B2E4
P50
description
researcher ORCID ID = 0000-0002-0580-373X
@en
wetenschapper
@nl
name
Rikke Nørregaard
@ast
Rikke Nørregaard
@en
Rikke Nørregaard
@es
Rikke Nørregaard
@nl
type
label
Rikke Nørregaard
@ast
Rikke Nørregaard
@en
Rikke Nørregaard
@es
Rikke Nørregaard
@nl
prefLabel
Rikke Nørregaard
@ast
Rikke Nørregaard
@en
Rikke Nørregaard
@es
Rikke Nørregaard
@nl
P106
P21
P31
P496
0000-0002-0580-373X